Annual report
2931.TEDINET S100QG7X
Period2022-01-01 → 2022-12-31
Filed2023-03-27
StandardJapan GAAP
ConsolidatedYes
Data checks21 of 22 passed
Key figures · 64
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥44.4bn | 2022-01-01 → 2022-12-31 | Cons. | Net sales |
| Revenue | ¥34.4bn | 2020-10-01 → 2021-12-31 | Cons. | Net sales |
| Operating income | −¥3.5bn | 2022-01-01 → 2022-12-31 | Cons. | Operating income |
| Operating income | −¥6.6bn | 2020-10-01 → 2021-12-31 | Cons. | Operating income |
| Ordinary income | −¥2.5bn | 2022-01-01 → 2022-12-31 | Cons. | Ordinary income |
| Ordinary income | −¥6.4bn | 2020-10-01 → 2021-12-31 | Cons. | Ordinary income |
| Profit before tax | −¥2.4bn | 2022-01-01 → 2022-12-31 | Cons. | Income before income taxes |
| Profit before tax | −¥6.7bn | 2020-10-01 → 2021-12-31 | Cons. | Income before income taxes |
| Net income (owners) | −¥2.7bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥5.0bn | 2020-10-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥2.7bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss |
| Net income | −¥5.8bn | 2020-10-01 → 2021-12-31 | Cons. | Profit loss |
| Total assets | ¥57.3bn | at 2022-12-31 | Cons. | Assets |
| Total assets | ¥61.0bn | at 2021-12-31 | Cons. | Assets |
| Total liabilities | ¥37.9bn | at 2022-12-31 | Cons. | Liabilities |
| Total liabilities | ¥40.4bn | at 2021-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥19.4bn | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥20.6bn | at 2021-12-31 | Cons. | Net assets |
| Cash and deposits | ¥10.0bn | at 2022-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥9.9bn | at 2021-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥9.8bn | at 2022-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥9.8bn | at 2021-12-31 | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥924m | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.4bn | 2020-10-01 → 2021-12-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | ¥1.2bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥10.3bn | 2020-10-01 → 2021-12-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥3.0bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥12.1bn | 2020-10-01 → 2021-12-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-23.83 | 2022-01-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-49.07 | 2020-10-01 → 2021-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥167.34 | at 2022-12-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥181.35 | at 2021-12-31 | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 33.0% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.0% | at 2021-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Employees | 865 | at 2022-12-31 | Cons. | Number of employees |
| Employees | 883 | at 2021-12-31 | Cons. | Number of employees |
| Revenue | ¥6.5bn | 2022-01-01 → 2022-12-31 | Standalone | Net sales |
| Revenue | ¥9.5bn | 2020-10-01 → 2021-12-31 | Standalone | Net sales |
| Operating income | −¥3.5bn | 2022-01-01 → 2022-12-31 | Standalone | Operating income |
| Operating income | −¥3.4bn | 2020-10-01 → 2021-12-31 | Standalone | Operating income |
| Ordinary income | −¥2.2bn | 2022-01-01 → 2022-12-31 | Standalone | Ordinary income |
| Ordinary income | −¥2.6bn | 2020-10-01 → 2021-12-31 | Standalone | Ordinary income |
| Profit before tax | −¥2.6bn | 2022-01-01 → 2022-12-31 | Standalone | Income before income taxes |
| Profit before tax | −¥2.7bn | 2020-10-01 → 2021-12-31 | Standalone | Income before income taxes |
| Net income | −¥2.7bn | 2022-01-01 → 2022-12-31 | Standalone | Profit loss |
| Net income | −¥2.4bn | 2020-10-01 → 2021-12-31 | Standalone | Profit loss |
| Total assets | ¥26.7bn | at 2022-12-31 | Standalone | Assets |
| Total assets | ¥27.8bn | at 2021-12-31 | Standalone | Assets |
| Total liabilities | ¥5.2bn | at 2022-12-31 | Standalone | Liabilities |
| Total liabilities | ¥5.5bn | at 2021-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥21.5bn | at 2022-12-31 | Standalone | Net assets |
| Net assets / equity | ¥22.3bn | at 2021-12-31 | Standalone | Net assets |
| Cash and deposits | ¥2.9bn | at 2022-12-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥4.9bn | at 2021-12-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥-23.9 | 2022-01-01 → 2022-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-22.94 | 2020-10-01 → 2021-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥186.11 | at 2022-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥197.18 | at 2021-12-31 | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 78.8% | at 2022-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.8% | at 2021-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 113,105,455 | at 2022-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 111,161,886 | at 2021-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Employees | 250 | at 2022-12-31 | Standalone | Number of employees |
| Employees | 212 | at 2021-12-31 | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 62
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2022-01-01 → 2022-12-31 | ¥1m |
| Reconciling Itemsreconciling | depreciation | 2022-01-01 → 2022-12-31 | ¥50m |
| Reconciling Itemsreconciling | segment assets | at 2022-12-31 | ¥3.4bn |
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-12-31 | −¥1.7bn |
| Biofuel Businessreportable segment | capex | 2022-01-01 → 2022-12-31 | ¥22m |
| Biofuel Businessreportable segment | depreciation | 2022-01-01 → 2022-12-31 | ¥49m |
| Biofuel Businessreportable segment | employees | at 2022-12-31 | 43 pure |
| Biofuel Businessreportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥262m |
| Biofuel Businessreportable segment | revenue external | 2022-01-01 → 2022-12-31 | ¥262m |
| Biofuel Businessreportable segment | segment assets | at 2022-12-31 | ¥947m |
| Biofuel Businessreportable segment | segment profit | 2022-01-01 → 2022-12-31 | −¥789m |
| Health Care Businessreportable segment | capex | 2022-01-01 → 2022-12-31 | ¥406m |
| Health Care Businessreportable segment | depreciation | 2022-01-01 → 2022-12-31 | ¥2.2bn |
| Health Care Businessreportable segment | employees | at 2022-12-31 | 655 pure |
| Health Care Businessreportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥41.6bn |
| Health Care Businessreportable segment | revenue external | 2022-01-01 → 2022-12-31 | ¥41.6bn |
| Health Care Businessreportable segment | segment assets | at 2022-12-31 | ¥49.6bn |
| Health Care Businessreportable segment | segment profit | 2022-01-01 → 2022-12-31 | −¥638m |
| Others Businessreportable segment | capex | 2022-01-01 → 2022-12-31 | ¥48m |
| Others Businessreportable segment | depreciation | 2022-01-01 → 2022-12-31 | ¥34m |
| Others Businessreportable segment | employees | at 2022-12-31 | 113 pure |
| Others Businessreportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥2.5bn |
| Others Businessreportable segment | revenue external | 2022-01-01 → 2022-12-31 | ¥2.5bn |
| Others Businessreportable segment | segment assets | at 2022-12-31 | ¥3.3bn |
| Others Businessreportable segment | segment profit | 2022-01-01 → 2022-12-31 | −¥325m |
| —segment total | capex | 2022-01-01 → 2022-12-31 | ¥477m |
| —segment total | depreciation | 2022-01-01 → 2022-12-31 | ¥2.3bn |
| —segment total | revenue | 2022-01-01 → 2022-12-31 | ¥44.4bn |
| —segment total | revenue external | 2022-01-01 → 2022-12-31 | ¥44.4bn |
| —segment total | segment assets | at 2022-12-31 | ¥53.9bn |
| —segment total | segment profit | 2022-01-01 → 2022-12-31 | −¥1.8bn |
| Reconciling Itemsreconciling | capex | 2020-10-01 → 2021-12-31 | ¥31m |
| Reconciling Itemsreconciling | depreciation | 2020-10-01 → 2021-12-31 | ¥94m |
| Reconciling Itemsreconciling | segment assets | at 2021-12-31 | ¥5.7bn |
| Reconciling Itemsreconciling | segment profit | 2020-10-01 → 2021-12-31 | −¥2.2bn |
| Biofuel Businessreportable segment | capex | 2020-10-01 → 2021-12-31 | ¥37m |
| Biofuel Businessreportable segment | depreciation | 2020-10-01 → 2021-12-31 | ¥110m |
| Biofuel Businessreportable segment | revenue | 2020-10-01 → 2021-12-31 | ¥47m |
| Biofuel Businessreportable segment | revenue external | 2020-10-01 → 2021-12-31 | ¥47m |
| Biofuel Businessreportable segment | segment assets | at 2021-12-31 | ¥602m |
| Biofuel Businessreportable segment | segment profit | 2020-10-01 → 2021-12-31 | −¥1.2bn |
| Health Care Businessreportable segment | capex | 2020-10-01 → 2021-12-31 | ¥387m |
| Health Care Businessreportable segment | depreciation | 2020-10-01 → 2021-12-31 | ¥1.5bn |
| Health Care Businessreportable segment | revenue | 2020-10-01 → 2021-12-31 | ¥33.7bn |
| Health Care Businessreportable segment | revenue external | 2020-10-01 → 2021-12-31 | ¥33.7bn |
| Health Care Businessreportable segment | segment assets | at 2021-12-31 | ¥52.1bn |
| Health Care Businessreportable segment | segment profit | 2020-10-01 → 2021-12-31 | −¥2.8bn |
| Others Businessreportable segment | capex | 2020-10-01 → 2021-12-31 | ¥54m |
| Others Businessreportable segment | depreciation | 2020-10-01 → 2021-12-31 | ¥14m |
| Others Businessreportable segment | revenue | 2020-10-01 → 2021-12-31 | ¥627m |
| Others Businessreportable segment | revenue external | 2020-10-01 → 2021-12-31 | ¥627m |
| Others Businessreportable segment | segment assets | at 2021-12-31 | ¥2.6bn |
| Others Businessreportable segment | segment profit | 2020-10-01 → 2021-12-31 | −¥373m |
| —segment total | capex | 2020-10-01 → 2021-12-31 | ¥479m |
| —segment total | depreciation | 2020-10-01 → 2021-12-31 | ¥1.6bn |
| —segment total | revenue | 2020-10-01 → 2021-12-31 | ¥34.4bn |
| —segment total | revenue external | 2020-10-01 → 2021-12-31 | ¥34.4bn |
| —segment total | segment assets | at 2021-12-31 | ¥55.3bn |
| —segment total | segment profit | 2020-10-01 → 2021-12-31 | −¥4.4bn |
| Biofuel Businessreportable segment | employees | at 2022-12-31 | 43 pure |
| Health Care Businessreportable segment | employees | at 2022-12-31 | 127 pure |
| Others Businessreportable segment | employees | at 2022-12-31 | 25 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,625
| Item | Context | Value | Unit |
|---|---|---|---|
| Total assets (5-year summary) | Prior2YearInstant | 15351000000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 61007000000 | JPY |
| Total assets (5-year summary) | CurrentYearInstant | 57275000000 | JPY |
| Net assets per share (5-year summary) | Prior4YearInstant | 185.44 | |
| Net assets per share (5-year summary) | Prior3YearInstant | 116.45 | |
| Net assets per share (5-year summary) | Prior2YearInstant | 100.58 | |
| Net assets per share (5-year summary) | Prior1YearInstant | 181.35 | |
| Net assets per share (5-year summary) | CurrentYearInstant | 167.34 | |
| Basic earnings loss per share (5-year summary) | Prior4YearDuration | -14.70 | |
| Basic earnings loss per share (5-year summary) | Prior3YearDuration | -107.25 | |
| Basic earnings loss per share (5-year summary) | Prior2YearDuration | -16.00 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | -49.07 | |
| Basic earnings loss per share (5-year summary) | CurrentYearDuration | -23.83 | |
| Diluted earnings per share (5-year summary) | Prior4YearDuration | － | |
| Diluted earnings per share (5-year summary) | Prior3YearDuration | － | |
| Diluted earnings per share (5-year summary) | Prior2YearDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior4YearInstant | 0.727 | |
| Equity to asset ratio (5-year summary) | Prior3YearInstant | 0.629 | |
| Equity to asset ratio (5-year summary) | Prior2YearInstant | 0.610 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.330 | |
| Equity to asset ratio (5-year summary) | CurrentYearInstant | 0.330 | |
| Rate of return on equity (5-year summary) | Prior4YearDuration | － | |
| Rate of return on equity (5-year summary) | Prior3YearDuration | － | |
| Rate of return on equity (5-year summary) | Prior2YearDuration | － | |
| Rate of return on equity (5-year summary) | Prior1YearDuration | － | |
| Rate of return on equity (5-year summary) | CurrentYearDuration | － | |
| Price earnings ratio (5-year summary) | Prior4YearDuration | － | |
| Price earnings ratio (5-year summary) | Prior3YearDuration | － | |
| Price earnings ratio (5-year summary) | Prior2YearDuration | － | |
| Price earnings ratio (5-year summary) | Prior1YearDuration | － | |
| Price earnings ratio (5-year summary) | CurrentYearDuration | － | |
| Net cash provided by used in operating activities (5-year summary) | Prior4YearDuration | -1238000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior3YearDuration | 1089000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior2YearDuration | -1217000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | 1378000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYearDuration | 924000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior4YearDuration | -3889000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior3YearDuration | -1436000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior2YearDuration | -350000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -10338000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYearDuration | 1233000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior4YearDuration | 2317000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior3YearDuration | 2713000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior2YearDuration | 162000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | 12062000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYearDuration | -2993000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior4YearInstant | 4426000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior3YearInstant | 7791000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 21 of 22 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | partial |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |